Hear from Prof Miles Prince as he provides an update on the impact of the Coronavirus on the management of your blood cancer. His top tips were: • Get the flu shot it is available now • Keep in contact with your treating doctor • Don’t be scared of going to the hospital for your … Continued
Snowdome Foundation took the opportunity to film Prof Miles Prince AM as he spoke about his advice to blood cancer patients during COVID 19. We hope you find this video useful and reassuring. Please click on the image to hear what Miles had to say.
We are proud to share with you the Snowdome Foundation 2019 Annual Review. The review celebrates 10 years of ‘making hope real’ for Australian blood cancer patients. We hope you are just as proud of our achievements as we are because we truly believe that every donation, every pro bono offer of support and every … Continued
18 months ago Snowdome spoke with Amanda Lindell while she was in the middle of treatment for her chronic lymphocytic leukaemia (CLL). CLL generally affects people 20 years older than Amanda and is usually a very slow cancer, smouldering away in the background. However, Amanda was young and her CLL was progressing rapidly. Her haematologist … Continued
Myeloma is a cancer of the plasma cells. Your plasma cells are responsible for your immunity, they secrete large quantities of antibodies to fight off infection. Finding an effective treatment for myeloma has unfortunately baffled researchers for decades. Prof Stephen Nutt and his colleagues at the Walter Eliza Hall Institute are taking a different approach … Continued
The Medical Services Advisory Committee (MSAC) has given a positive recommendation to Kymriah a CAR T-cell therapy to treat refractory or relapsed diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) including transformed, and primary mediastinal B-cell lymphoma (PMBCL). The treatment would cost an individual up to $500,000 but will now be funded by the government. In … Continued
Professor Ricky Johnstone is the Head of the Gene Regulation Laboratory at the Peter MacCallum Cancer Centre and the Head, The Sir Peter MacCallum Department of Oncology, The University of Melbourne. He is the recipient of the Leukemia & Lymphoma Society-Snowdome Foundation–Leukaemia Foundation Translational Research grant. His mission is to uncover a new therapy to … Continued
We are deeply saddened to hear the news of Tom Long passing. Tom was an inspiration to many. He bravely shared his journey with multiple myeloma with the world, not because he wanted the attention but because he strongly believed it would help others. He has raised awareness, lifted spirits, gave many hope and made … Continued
Wonderful to see the FDA, TGA and Canadian regulatory authorities working together to approve a new treatment for refractory/ relapsed Chronic Lymphocytic Leukaemia (CLL). Acalabrutinib is a second-generation BTK (Bruton’s tyrosine kinase or tyrosine-protein kinase) and was shown to be more effective and more tolerable than usual treatments. We look forward to seeing this treatment … Continued